SEC Form 4 · accession 0001235802-18-000185
DiaMedica Therapeutics Inc. · DMAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zhenyu Xiao
Director · 10% Owner
Period of report
Dec 11, 2018
Accepted (ET)
Dec 11, 2018 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401040
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, no par value per shareF1 | Dec 11, 2018 | P | 3,250 | $4.00 | A | 7,100 | D | |
| Voting Common Shares, no par value per shareF2 | holding | — | — | — | 1,000,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- F2These voting common shares are held by Hermeda Industrial Co., Limited, Zhenyu Xiao, Ph.D. is the Director of Hermeda Industrial Co., Limited and has sole voting and dispositive power over the voting common shares held by Hermeda Industrial Co., Limited.